CompletedNCT02378714
Behavioral Activation and Varenicline for Smokers With Depression
About this title
Read the official source — NCT02378714Medication studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Chicago and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: July 24, 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 300
- Sponsor
- Northwestern University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT02378714
- Official title
Show the full official title
Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago · Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwestern University, a university.
Did this study involve medication?
Yes. The study involved medication, including Varenicline.
Who was this study for?
Listed age limits: from 18 years.
